EYLEA

Aflibercept · Regeneron Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

120 regulatory and trial events tracked for EYLEA, covering 2011-11-18 to 2026-08-21. Get the full timeline:

Most recent: EMA Authorised: Eylea (aflibercept) — Bayer AG